Fortrea Q3 2023 Earnings Report $17.64 -0.67 (-3.66%) As of 01/14/2025 04:00 PM Eastern Earnings HistoryForecast Fortrea EPS ResultsActual EPS$0.24Consensus EPS $0.16Beat/MissBeat by +$0.08One Year Ago EPSN/AFortrea Revenue ResultsActual Revenue$776.40 millionExpected Revenue$748.90 millionBeat/MissBeat by +$27.50 millionYoY Revenue Growth+1.80%Fortrea Announcement DetailsQuarterQ3 2023Date11/13/2023TimeBefore Market OpensConference Call ResourcesConference CallPress ReleaseSEC FilingFTRE Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Powered by Fortrea Earnings HeadlinesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTREJanuary 8, 2025 | prnewswire.comHere’s Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By Activist Hedge FundsJanuary 3, 2025 | msn.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.January 15, 2025 | Crypto Swap Profits (Ad)15 Stocks Targeted By Activist Hedge FundsJanuary 2, 2025 | insidermonkey.comFortrea Holdings Inc put volume heavy and directionally bearishJanuary 2, 2025 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTREJanuary 2, 2025 | prnewswire.comSee More Fortrea Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email. Email Address About FortreaFortrea (NASDAQ:FTRE), a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.View Fortrea ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings Infosys (1/16/2025)Bank of America (1/16/2025)U.S. Bancorp (1/16/2025)Morgan Stanley (1/16/2025)The PNC Financial Services Group (1/16/2025)Taiwan Semiconductor Manufacturing (1/16/2025)UnitedHealth Group (1/16/2025)Schlumberger (1/17/2025)Truist Financial (1/17/2025)Netflix (1/21/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
